{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:21:34Z","timestamp":1788780094415,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21HD101996"],"award-info":[{"award-number":["R21HD101996"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/Office of Research on Women\u2019s Health","award":["K12HD043441"],"award-info":[{"award-number":["K12HD043441"]}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-US-342-5634"],"award-info":[{"award-number":["IN-US-342-5634"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir (SOF)\/velpatasvir (VEL) in pregnant versus nonpregnant people.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Pregnant people with chronic HCV infection were enrolled between 23 and 25 weeks\u2019 gestation and were provided SOF\/VEL daily for 12 weeks. PK visits were performed at 3, 6, and 9 weeks. VEL, SOF, and GS-331007 (the inactive metabolite of SOF) in plasma and the SOF active metabolite (007-TP) in peripheral blood mononuclear cells (PBMCs) and dried blood spots (DBSs) were measured and compared to historical data in nonpregnant people. Maternal adverse events, delivery outcomes, the sustained virologic response 12 weeks after therapy, infant adverse events, and HCV perinatal transmission were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen participants were screened, and 11 enrolled. One participant discontinued treatment due to worsening of hyperemesis. VEL area under the curve (AUC) was similar to historic data in nonpregnant people, but the AUCs of SOF and GS-331007 were 38% higher and 38% lower, respectively. Concentrations of 007-TP in PBMCs were comparable or higher, whereas 007-TP in DBSs was approximately 50% lower in pregnant versus nonpregnant people. All 10 participants who completed treatment had undetectable HCV RNA at delivery. Two participants were lost to follow-up after delivery, but 1 had an HCV RNA through clinical care. All participants with data were cured (n = 9) and none of the infants acquired HCV (n = 8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SOF\/VEL exposures were not clinically different in pregnancy and support further evaluation of antenatal SOF\/VEL treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciae595","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T23:26:56Z","timestamp":1733354816000},"page":"744-751","source":"Crossref","is-referenced-by-count":15,"title":["Sofosbuvir\/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-3765","authenticated-orcid":false,"given":"Catherine A","family":"Chappell","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J","family":"Kiser","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-8699","authenticated-orcid":false,"given":"Kristina M","family":"Brooks","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Randolph","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid S","family":"Macio","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-9878","authenticated-orcid":false,"given":"Leslie A","family":"Meyn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"MaWhinney","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Rick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2476-4008","authenticated-orcid":false,"given":"Gysella B","family":"Muniz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung min","family":"Kwon","sequence":"additional","affiliation":[{"name":"Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Letterio","sequence":"additional","affiliation":[{"name":"Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarjita","family":"Naik","sequence":"additional","affiliation":[{"name":"Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Kreter","sequence":"additional","affiliation":[{"name":"Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E","family":"Bunge","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E","family":"Krans","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L","family":"Hillier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"2025043020384806900_ciae595-B1","article-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024"},{"key":"2025043020384806900_ciae595-B2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(20)30359-9","article-title":"Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study","volume":"6","author":"Dugan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025043020384806900_ciae595-B3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10995-019-02841-1","article-title":"Estimates of prenatal HIV, hepatitis B virus, and hepatitis C virus testing among pregnant people enrolled in Wisconsin Medicaid, 2011\u20132015","volume":"24","author":"Watts","year":"2020","journal-title":"Matern Child Health J"},{"key":"2025043020384806900_ciae595-B4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","article-title":"Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014","volume":"166","author":"Ly","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025043020384806900_ciae595-B5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.15585\/mmwr.mm6528a2","article-title":"Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission\u2014United States and Kentucky, 2011\u20132014","volume":"65","author":"Koneru","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025043020384806900_ciae595-B6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth\u2014Tennessee and United States, 2009\u20132014","volume":"66","author":"Patrick","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025043020384806900_ciae595-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2025043020384806900_ciae595-B8","author":"American College of Obstetricians and Gynecologists"},{"key":"2025043020384806900_ciae595-B9","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.ajog.2021.06.008","article-title":"Society for Maternal-Fetal Medicine consult series #56: hepatitis C in pregnancy-updated guidelines: replaces consult #43, November 2017","volume":"225","author":"Dotters-Katz","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025043020384806900_ciae595-B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08897077.2015.1118720","article-title":"Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"2025043020384806900_ciae595-B11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1055\/s-0041-1728827","article-title":"Pragmatic experience with risk-based versus universal hepatitis C screening in pregnancy: detection of infection and postpartum linkage to care","volume":"38","author":"Bushman","year":"2021","journal-title":"Am J Perinatol"},{"key":"2025043020384806900_ciae595-B12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000004760","article-title":"Postpartum follow-up care for pregnant persons with opioid use disorder and hepatitis C virus infection","volume":"139","author":"Jarlenski","year":"2022","journal-title":"Obstet Gynecol"},{"key":"2025043020384806900_ciae595-B13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ADM.0000000000001266","article-title":"Postpartum treatment for chronic hepatitis C virus among people with opioid use disorder: a prospective pilot clinical trial","volume":"18","author":"Chappell","year":"2024","journal-title":"J Addict Med"},{"key":"2025043020384806900_ciae595-B14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"2025043020384806900_ciae595-B15","article-title":"Recommendations for the use of antiretroviral drugs to prevent perinatal HIV transmission and improve health for pregnant people","author":"National Institutes of Health","year":"2024"},{"key":"2025043020384806900_ciae595-B16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ogc.2023.02.008","article-title":"Hepatitis C virus in pregnancy: an opportunity to test and treat","volume":"50","author":"Fogel","year":"2023","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2025043020384806900_ciae595-B17","article-title":"HCV guidance: HCV in pregnancy","author":"American Association for the Study of Liver Diseases\/Infectious Diseases Society of America","year":"2023"},{"key":"2025043020384806900_ciae595-B18","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"key":"2025043020384806900_ciae595-B19","article-title":"Hepatitis C. Red Book: 2021\u20132024 report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021"},{"key":"2025043020384806900_ciae595-B20","author":"Division of AIDS","year":"2017"},{"key":"2025043020384806900_ciae595-B21","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1128\/AAC.01693-15","article-title":"Validation and application of a liquid chromatography\u2013tandem mass spectrometry method to determine the concentrations of sofosbuvir anabolites in cells","volume":"59","author":"Rower","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020384806900_ciae595-B22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jac\/dkac051","article-title":"Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use","volume":"77","author":"Brooks","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025043020384806900_ciae595-B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ucl.2006.10.008","article-title":"Anatomic and functional changes of the upper urinary tract during pregnancy","volume":"34","author":"Jeyabalan","year":"2007","journal-title":"Urol Clin North Am"},{"key":"2025043020384806900_ciae595-B24","article-title":"Epclusa prescribing information","author":"Gilead Sciences","year":"2021"},{"key":"2025043020384806900_ciae595-B25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ncl.2012.05.001","article-title":"Physiologic adaptations to pregnancy","volume":"30","author":"Chang","year":"2012","journal-title":"Neurol Clin"},{"key":"2025043020384806900_ciae595-B26","doi-asserted-by":"crossref","first-page":"E1893","DOI":"10.1093\/cid\/ciaa1872","article-title":"Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa","volume":"73","author":"Stranix-Chibanda","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025043020384806900_ciae595-B27","first-page":"134","article-title":"Safety and efficacy of treatment for chronic hepatitis C during pregnancy: a prospective observational study in Srinagar, India","volume":"22","author":"Yattoo","year":"2023","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2025043020384806900_ciae595-B28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2022.07.017","article-title":"Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach","volume":"163","author":"Kushner","year":"2022","journal-title":"Gastroenterology"},{"key":"2025043020384806900_ciae595-B29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2468-1253(22)00168-6","article-title":"Hepatitis C in pregnancy and the TiP-HepC registry","volume":"7","author":"Gupta","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025043020384806900_ciae595-B30","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.11.002","article-title":"Society for Maternal-Fetal Medicine consult series #53: intrahepatic cholestasis of pregnancy: replaces consult #13, April 2011","volume":"224","author":"Lee","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025043020384806900_ciae595-B31","doi-asserted-by":"crossref","first-page":"e20173273","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"key":"2025043020384806900_ciae595-B32","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/liv.15672","article-title":"Outcomes of accidental pregnancy during chronic hepatitis C treatment with direct-acting antiviral agents","volume":"43","author":"El-Kassas","year":"2023","journal-title":"Liver Int"},{"key":"2025043020384806900_ciae595-B33","author":"International Maternal Pediatric Adolescent AIDS Clinical Trials Network"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae595\/61182972\/ciae595.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/744\/61182972\/ciae595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/744\/61182972\/ciae595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:39:01Z","timestamp":1746045541000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/4\/744\/7924154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,17]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae595","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2024,12,17]]}}}